ST Elevation Myocardial Infarction

1
Pipeline Programs
7
Companies
12
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
TicagrelorPhase 21 trial
Active Trials
NCT03145194Unknown140Est. Nov 2019
Abbott
AbbottABBOTT PARK, IL
2 programs
Continuous Saline ThermodilutionN/A1 trial
angiographyN/A5 trials
Active Trials
NCT06795035Recruiting70Est. Dec 2027
NCT04748965Completed40Est. Jun 2024
NCT04996277Unknown300Est. Mar 2024
+3 more trials
HeartFlow
HeartFlowMOUNTAIN VIEW, CA
1 program
CT Coronary AngiographyN/A1 trial
Active Trials
NCT06506448RecruitingEst. Jan 2029
Pulse Biosciences
Pulse BiosciencesCA - Hayward
1 program
PCIN/A1 trial
Active Trials
NCT04259853UnknownEst. Feb 2026
Miracor Medical
Miracor MedicalBelgium - Awans
1 program
PICSON/A1 trial
Active Trials
NCT03473015CompletedEst. Oct 2020
Acist Medical Systems
Acist Medical SystemsMN - Eden Prairie
1 program
Tissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular N/A1 trial
Active Trials
NCT05007535UnknownEst. Feb 2023
PEEL Therapeutics
PEEL TherapeuticsUT - Salt Lake City
1 program
autoRICN/A1 trial
Active Trials
NCT03265067CompletedEst. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
AstraZenecaTicagrelor
AbbottContinuous Saline Thermodilution
HeartFlowCT Coronary Angiography
Abbottangiography
Abbottangiography
Acist Medical SystemsTissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular
Abbottangiography
Pulse BiosciencesPCI
Abbottangiography
PEEL TherapeuticsautoRIC
Miracor MedicalPICSO
Abbottangiography

Clinical Trials (12)

Total enrollment: 1,022 patients across 12 trials

NCT03145194AstraZenecaTicagrelor

TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI

Start: Jan 2017Est. completion: Nov 2019140 patients
Phase 2Unknown
NCT06795035AbbottContinuous Saline Thermodilution

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

Start: May 2025Est. completion: Dec 202770 patients
N/ARecruiting
NCT06506448HeartFlowCT Coronary Angiography

Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease

Start: Jan 2025Est. completion: Jan 2029
N/ARecruiting
NCT04748965Abbottangiography

Imaging-Guided Vessel Sizing in the Tibial Arteries

Start: Aug 2021Est. completion: Jun 202440 patients
N/ACompleted
NCT04996277Abbottangiography

A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI

Start: Jul 2021Est. completion: Mar 2024300 patients
N/AUnknown
NCT05007535Acist Medical SystemsTissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular

Tissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular Ultrasound

Start: Nov 2020Est. completion: Feb 2023
N/AUnknown
NCT04356027Abbottangiography

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Start: Jun 2020Est. completion: Oct 2021312 patients
N/ACompleted
NCT04259853Pulse BiosciencesPCI

Quantitative Fractional Ratio-guided Revascularization in STEMI Patients With Multi-vessel Disease

Start: Jan 2020Est. completion: Feb 2026
N/AUnknown
NCT03237169Abbottangiography

Performance of a New REsting Pressure Index During Invasive Angiography Compared To Adenosine Hyperemic FFR

Start: Oct 2016Est. completion: Sep 2018100 patients
N/AUnknown
NCT03265067PEEL TherapeuticsautoRIC

Field Implementation of the autoRIC Device in STEMI

Start: Jul 2016Est. completion: Jul 2019
N/ACompleted
NCT03473015Miracor MedicalPICSO

Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion

Start: Jul 2015Est. completion: Oct 2020
N/ACompleted
NCT02234804Abbottangiography

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

Start: Jul 2013Est. completion: Feb 201760 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,022 patients
7 companies competing in this space